AEGON Asset Management (UK)’s AstraZeneca AZN Stock Holding History

AEGON Asset Management (UK)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$357M	Buy	+1,905,111	New	+$358M	3.8%	5
2024 Q2	–	Sell	-53,230	Closed	-$7.21M	–	144
2024 Q1	$7.21M	Sell	53,230 -47,455	-47%	-$6.28M	0.11%	98
2023 Q4	$13.6M	Buy	+100,685	New	+$13.1M	0.22%	86
2023 Q2	$15.2M	Sell	106,047 -878	-0.8%	-$129K	0.25%	86
2023 Q1	$14.8M	Sell	106,925 -20,602	-16%	-$2.77M	0.26%	87
2022 Q4	$17.3M	Sell	127,527 -36,108	-22%	-$4.53M	0.31%	81
2022 Q3	$17.9M	Hold	163,635	–	–	0.36%	69
2022 Q2	$21.6M	Sell	163,635 -48,912	-23%	-$6.42M	0.41%	64
2022 Q1	$28.2M	Hold	212,547	–	–	0.42%	71
2021 Q4	$24.7M	Sell	212,547 -6,854	-3%	-$806K	0.32%	80
2021 Q3	$26.4M	Hold	219,401	–	–	0.37%	82
2021 Q2	$26.3M	Sell	219,401 -13,414	-6%	-$1.47M	0.37%	83
2021 Q1	$23.1M	Sell	232,815 -72,643	-24%	-$7.3M	0.34%	90
2020 Q4	$30.5M	Buy	+305,458	New	+$32.4M	0.45%	80

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AEGON Asset Management (UK)'s AZN Position: Q2 2026 in Review

AEGON Asset Management (UK) opened a new position in AstraZeneca (AZN) in Q2 2026: 1,905,111 shares worth $357M. The stake represents 3.8% of the portfolio and ranks #5 among its holdings. This is a return to the name: AEGON Asset Management (UK) previously reported a position in AZN as recently as Q1 2024.

AEGON Asset Management (UK) first reported a position in AZN in Q4 2020 and has held it in 14 quarters since. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

AEGON Asset Management (UK) held 1,905,111 shares of AstraZeneca worth $357M as of Q2 2026.
AstraZeneca was a new AEGON Asset Management (UK) position in Q2 2026.
AstraZeneca made up 3.8% of AEGON Asset Management (UK)'s portfolio in Q2 2026, its #5 holding.
AEGON Asset Management (UK) first reported a position in AstraZeneca in Q4 2020 and has held it in 14 quarters since.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on AEGON Asset Management (UK)'s 13F filing for Q2 2026, filed 13 Jul 2026.